Literature DB >> 17513465

Public health surveillance for coccidioidomycosis in Arizona.

Rebecca H Sunenshine1, Shoana Anderson, Laura Erhart, Anne Vossbrink, Peter C Kelly, David Engelthaler, Kenneth Komatsu.   

Abstract

Coccidioidomycosis or Valley Fever is a fungal disease that occurs primarily in the southwestern United States. Of the estimated 150,000 U. S. coccidioidomycosis infections per year, approximately 60% occur in Arizona, making this state the focal point for investigation of the disease. In this manuscript, we describe the epidemiology of coccidioidomycosis reported in Arizona over the last decade, hypotheses for the findings, and Arizona's response to the rising epidemic. Coccidioidomycosis surveillance data in Arizona consist of basic demographics of all laboratory and physician-diagnosed cases, the reporting of which has been mandated by law since 1997. The rate of reported coccidioidomycosis has more than quadrupled over the last decade from 21 cases per 100,000 population in 1997 to 91 cases per 100,000 in 2006 (P < 0.001). Case rates in older age groups (>/=65 years old) have more than doubled since 2000 (P < 0.001). These data demonstrate the rising coccidioidomycosis epidemic in Arizona, especially among the elderly. The increase in the numbers of reported cases can be partially explained by the institution of mandatory laboratory reporting in 1997, but the cause of the persistent rise after 1999 is unknown. Further investigation of coccidioidomycosis will not only assist with the development of public health interventions to control this disease in Arizona and the southwestern United States, but will also provide important information to prepare for a bioterrorism event caused by this select agent.

Entities:  

Mesh:

Year:  2007        PMID: 17513465     DOI: 10.1196/annals.1406.045

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

Review 1.  An insight into the antifungal pipeline: selected new molecules and beyond.

Authors:  Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2010-08-20       Impact factor: 84.694

Review 2.  Update on the Epidemiology of coccidioidomycosis in the United States.

Authors:  Orion Z McCotter; Kaitlin Benedict; David M Engelthaler; Ken Komatsu; Kimberley D Lucas; Janet C Mohle-Boetani; Hanna Oltean; Duc Vugia; Tom M Chiller; Gail L Sondermeyer Cooksey; Alyssa Nguyen; Chandler C Roe; Charlotte Wheeler; Rebecca Sunenshine
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

3.  Hospitalized burden and outcomes of coccidioidomycosis: A nationwide analysis, 2005-2012.

Authors:  Ruihong Luo; Alan Greenberg; Christian D Stone
Journal:  Med Mycol       Date:  2017-06-01       Impact factor: 4.076

Review 4.  Coccidioidomycosis in African Americans.

Authors:  Barbara E Ruddy; Anita P Mayer; Marcia G Ko; Helene R Labonte; Jill A Borovansky; Erika S Boroff; Janis E Blair
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

5.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

Review 6.  Valley fever: danger lurking in a dust cloud.

Authors:  Larry Johnson; Erin M Gaab; Javier Sanchez; Phuong Q Bui; Clarissa J Nobile; Katrina K Hoyer; Michael W Peterson; David M Ojcius
Journal:  Microbes Infect       Date:  2014-07-16       Impact factor: 2.700

7.  A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.

Authors:  Jianmin Xue; Xia Chen; Dale Selby; Chiung-Yu Hung; Jieh-Juen Yu; Garry T Cole
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

Review 8.  Mycoses in the elderly.

Authors:  H Hof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-13       Impact factor: 3.267

9.  Coccidioidal meningitis: update on epidemiology, clinical features, diagnosis, and management.

Authors:  Janis E Blair
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

10.  Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004.

Authors:  Michelle M Kim; Janis E Blair; Elizabeth J Carey; Qing Wu; Jerry D Smilack
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.